At the 29th Semi-Annual Diagnostic Coverage and Reimbursement Conference, Dr. Ben Horton, MD, MHA, Avalon’s VP and Senior Medical Director, will engage in a fireside chat with Jennifer Fernandez from Caris Life Sciences to discuss the shifts in the constantly evolving regulatory landscape and explore the impact of FDA oversight of laboratory-developed tests (LDTs) into payment frameworks and its implications for reimbursement strategies, the essential need for compliance in precision medicine, and share insights from Avalon’s approach to making coverage decisions for laboratory tests, and much more.

To register, please visit Q1 Diagnostics.